MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 140 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $418,405 | -49.2% | 2,865 | -19.7% | 0.00% | -42.9% |
| Q2 2023 | $823,746 | -2.0% | 3,566 | +2.8% | 0.01% | -12.5% |
| Q1 2023 | $840,400 | -14.3% | 3,469 | +2.7% | 0.01% | -11.1% |
| Q4 2022 | $980,465 | +364.7% | 3,378 | +3.8% | 0.01% | +350.0% |
| Q3 2022 | $211,000 | -9.1% | 3,253 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $232,000 | -14.7% | 3,245 | +17.0% | 0.00% | 0.0% |
| Q1 2022 | $272,000 | +19.8% | 2,773 | +3.4% | 0.00% | 0.0% |
| Q4 2021 | $227,000 | +5.1% | 2,681 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $216,000 | -15.3% | 2,711 | +3.7% | 0.00% | 0.0% |
| Q2 2021 | $255,000 | -25.4% | 2,614 | -10.7% | 0.00% | -33.3% |
| Q1 2021 | $342,000 | +5.6% | 2,926 | +0.5% | 0.00% | 0.0% |
| Q4 2020 | $324,000 | -9.7% | 2,912 | -3.8% | 0.00% | -25.0% |
| Q3 2020 | $359,000 | +40.2% | 3,026 | +33.7% | 0.00% | 0.0% |
| Q2 2020 | $256,000 | – | 2,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |